| P2093 | author name string | Lei Zhang | |
| | Li Li | |
| | Jun Cao | |
| | Guang Chu | |
| | Jingfeng Li | |
| | Xiongqi Zhao | |
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis | Q26991768 |
| | Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update | Q27027703 |
| | Protection effect of kallistatin on carbon tetrachloride-induced liver fibrosis in rats via antioxidative stress | Q28539856 |
| | The roles of microRNA families in hepatic fibrosis | Q33868794 |
| | The Hedgehog transcription factor Gli3 modulates angiogenesis | Q35219195 |
| | A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis | Q35605375 |
| | Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation. | Q36232847 |
| | Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications | Q36304061 |
| | MicroRNAs: biogenesis and molecular functions. | Q37069470 |
| | Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies | Q37355850 |
| | Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152. | Q37665189 |
| | Mechanisms of hepatic fibrogenesis | Q37865859 |
| | Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives | Q38220772 |
| | The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats | Q38336979 |
| | Evaluation of Rumex hastatus leaves against hepatic fibrosis: a rat model. | Q38367906 |
| | Recent advancement of molecular mechanisms of liver fibrosis | Q38419194 |
| | Hepatic fibrosis: Concept to treatment | Q38446370 |
| | MicroRNAs in hepatic pathophysiology | Q38814131 |
| | Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets | Q39084507 |
| | Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. | Q39829317 |
| | Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis | Q40987376 |
| | MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. | Q41082375 |
| | Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3 | Q41144004 |
| | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis | Q41412732 |
| | Cytoplasmic domain of tissue factor promotes liver fibrosis in mice | Q41505574 |
| | MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway | Q44765599 |
| | MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1. | Q47995549 |
| | Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. | Q53576670 |
| | Glial fibrillary acidic protein as a marker of perisinusoidal stellate cells that can distinguish between the normal and myofibroblast-like phenotypes | Q73001085 |
| | Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same? | Q89641626 |
| P433 | issue | 1 | |
| P304 | page(s) | 425-434 | |
| P577 | publication date | 2019-05-20 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro | |
| P478 | volume | 18 | |